VH
DARE icon

Visionary Horizons’s Dare Bioscience DARE Stock Holding History

Visionary Horizons’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,104
Closed -$11.5K – 79
2023
Q4 		$11.5K Buy
+3,104
New +$14.2K 0.01% 80

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Visionary Horizons's DARE Position: Q1 2024 in Review

Visionary Horizons sold out of Dare Bioscience (DARE) in Q1 2024, closing a stake of 3,104 shares — an estimated $11.5K sold.

Visionary Horizons first reported a position in DARE in Q4 2023 and held it in 1 quarter. The position peaked at $11.5K in Q4 2023. 36 funds tracked by Wall St. Rank hold DARE as of Q1 2024.

  • Visionary Horizons reported no remaining Dare Bioscience position as of Q1 2024 after selling out during the quarter.
  • Visionary Horizons sold 3,104 Dare Bioscience shares in Q1 2024, an estimated $11.5K.
  • Visionary Horizons first reported a position in Dare Bioscience in Q4 2023 and held it in 1 quarter.
  • Visionary Horizons's Dare Bioscience position peaked at $11.5K in Q4 2023.
  • 36 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2024.

Based on Visionary Horizons's 13F filing for Q1 2024, filed 15 Apr 2024.